oncology
Medicines

Cemiplimab effective in advanced SCC

A new standard of care is on the horizon for advanced cutaneous squamous cell carcinoma (SCC), a leading Australian medical oncologist has told the ASCO meeting in Chicago. Professor Danny Rischin, Director of the Division of Cancer Medicine and Head of the Department of Medical Oncology at the Peter MacCallum Cancer Centre, presented the results ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic